Signaling_NN
events_NNS
induced_VBD
by_IN
lipopolysaccharide-activated_JJ
toll-like_JJ
receptor_NN
2_CD
._.

Human_JJ
Toll-like_JJ
receptor_NN
2_CD
-LRB-_-LRB-
TLR2_NN
-RRB-_-RRB-
is_VBZ
a_DT
signaling_NN
receptor_NN
that_WDT
responds_VBZ
to_TO
LPS_NN
and_CC
activates_VBZ
NF-kappaB_NN
._.

Here_RB
,_,
we_PRP
investigate_VBP
further_RB
the_DT
events_NNS
triggered_VBN
by_IN
TLR2_NN
in_IN
response_NN
to_TO
LPS_NN
._.

We_PRP
show_VBP
that_IN
TLR2_NN
associates_VBZ
with_IN
the_DT
high-affinity_JJ
LPS_NN
binding_NN
protein_NN
membrane_NN
CD14_NN
to_TO
serve_VB
as_IN
an_DT
LPS_NN
receptor_NN
complex_NN
,_,
and_CC
that_IN
LPS_NN
treatment_NN
enhances_VBZ
the_DT
oligomerization_NN
of_IN
TLR2_NN
._.

Concomitant_JJ
with_IN
receptor_NN
oligomerization_NN
,_,
the_DT
IL-1R-associated_JJ
kinase_NN
-LRB-_-LRB-
IRAK_NN
-RRB-_-RRB-
is_VBZ
recruited_VBN
to_TO
the_DT
TLR2_NN
complex_NN
._.

Intracellular_JJ
deletion_NN
variants_NNS
of_IN
TLR2_NN
lacking_VBG
C-terminal_JJ
13_CD
or_CC
141_CD
aa_NNS
fail_VBP
to_TO
recruit_VB
IRAK_NN
,_,
which_WDT
is_VBZ
consistent_JJ
with_IN
the_DT
inability_NN
of_IN
these_DT
mutants_NNS
to_TO
transmit_VB
LPS_NN
cellular_JJ
signaling_NN
._.

Moreover_RB
,_,
both_CC
deletion_NN
mutants_NNS
could_MD
still_RB
form_VB
complexes_NNS
with_IN
wild-type_JJ
TLR2_NN
and_CC
act_VB
in_IN
a_DT
dominant-negative_JJ
-LRB-_-LRB-
DN_JJ
-RRB-_-RRB-
fashion_NN
to_TO
block_VB
TLR2-mediated_JJ
signal_NN
transduction_NN
._.

DN_JJ
constructs_NNS
of_IN
myeloid_JJ
differentiation_NN
protein_NN
,_,
IRAK_NN
,_,
TNF_NN
receptor-associated_JJ
factor_NN
6_CD
,_,
and_CC
NF-kappaB-inducing_JJ
kinase_NN
,_,
when_WRB
coexpressed_VBN
with_IN
TLR2_NN
,_,
abrogate_VBP
TLR2-mediated_JJ
NF-kappaB_NN
activation_NN
._.

These_DT
results_NNS
reveal_VBP
a_DT
conserved_VBN
signaling_NN
pathway_NN
for_IN
TLR2_NN
and_CC
IL-1Rs_NNS
and_CC
suggest_VBP
a_DT
molecular_JJ
mechanism_NN
for_IN
the_DT
inhibition_NN
of_IN
TLR2_NN
by_IN
DN_JJ
variants_NNS
._.

